Dr. Rajiv B Nanavaty, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 150 Burnetts Way, Suite 320, Suffolk, VA 23434 Phone: 757-934-1900 Fax: 757-925-6719 |
Richard Kaye, D.O. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 2790 Godwin Blvd, Suite 300, Suffolk, VA 23434 Phone: 757-925-1433 Fax: 727-925-4567 |
Dr. Charles Steven Coleman, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 150 Burnetts Way, Suite 320, Suffolk, VA 23434 Phone: 757-934-1900 Fax: 757-925-6719 |
Dr. Tha T. U, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 2800 Godwin Blvd, Ste. 320, Suffolk, VA 23434 Phone: 757-934-4580 Fax: 757-934-4581 |
Dr. Nikolche J Naumovski, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1000 Commercial Ln, Western Tidwater Community Services Board, Suffolk, VA 23434 Phone: 757-942-1025 Fax: 757-925-2218 |
Dr. Melissa Faith Gross, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1000 Commercial Ln, Western Tidewater Community Services Board, Suffolk, VA 23434 Phone: 757-942-1025 Fax: 757-925-2218 |
News Archive
Roche Diabetes Care, makers of the ACCU-CHEK portfolio of diabetes management products and services, is pleased to announce the inaugural National Infusion Site Awareness Week, Aug. 30-Sept. 5. Roche made the announcement during the 37th annual American Association of Diabetes Educators (AADE) conference to highlight the important role that certified diabetes educators and other health care professionals play in promoting better site management for the 400,000 people in the United States with Type 1 diabetes who use an insulin pump.
In this New York Times opinion piece, author Tina Rosenberg reports on the use of food vouchers by some aid organizations in Somalia, highlighting the efforts of World Concern, "a Seattle-based Christian humanitarian group, and its Somali partner, the African Rescue Committee, [which] provide 1,800 families every two weeks with rice, beans, cooking oil, salt and sugar for their tea."
GPC Biotech AG has announced that the Oncologic Drugs Advisory Committee (ODAC) for the U.S. Food and Drug Administration (FDA) recommended (12-0) that the FDA should wait for the final survival analysis of the SPARC trial before deciding whether the satraplatin application is approvable for the treatment of hormone-refractory prostate cancer patients whose prior chemotherapy has failed.
Genzyme, a Sanofi company, today reported top-line results from TENERE, a Phase III clinical trial comparing the effectiveness, safety and tolerability of once-daily oral teriflunomide to interferon beta-1a, an approved injectable therapy, in people with relapsing forms of multiple sclerosis.
› Verified 6 days ago